Agilent (NYSE:A) had its estimates and price target increased by UBS (NYSE:UBS) as the firm believes the company can continue to gain market share during the next few quarters. A $51 price target was issued.
Shares are higher by about three tenths of a percent.
Jarden (NYSE:JAH) had its price target increased by Oppenheimer (NYSE:OPY) as the company has been experiencing a sales re-acceleration. An outperform rating was issued with a price target of $68.
Shares are higher by about six tenths of a percent.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.